Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124934582 | 12493458 | 2 | F | 20160712 | 20160623 | 20160725 | EXP | CZ-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-36783BI | BOEHRINGER INGELHEIM | CYRANY J,VASATKO T,NOVA M,HOVORKOVA E,MACHAC J,SZANYI J,ET AL. SARTAN ASSOCIATED ENTEROPATHY - CASE REPORT AND REVIEW OF THE LITERATURE. GASTROENTEROLOGIE A HEPATOLOGIC 2016;70:2:150-156. | 71.00 | YR | F | Y | 86.00000 | KG | 20160725 | OT | COUNTRY NOT SPECIFIED | CZ |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124934582 | 12493458 | 1 | PS | MICARDIS | TELMISARTAN | 1 | Unknown | 80 MG | Y | 20850 | 80 | MG | QD | ||||||
| 124934582 | 12493458 | 2 | C | RILMENIDINE | RILMENIDINE | 1 | Unknown | 0 | |||||||||||
| 124934582 | 12493458 | 3 | C | NITRENDIPINE | NITRENDIPINE | 1 | Unknown | 0 | |||||||||||
| 124934582 | 12493458 | 4 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 0 | |||||||||||
| 124934582 | 12493458 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 0 | |||||||||||
| 124934582 | 12493458 | 6 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 124934582 | 12493458 | 7 | C | INDAPAMIDE. | INDAPAMIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124934582 | 12493458 | 1 | Hypertension |
| 124934582 | 12493458 | 2 | Hypertension |
| 124934582 | 12493458 | 3 | Hypertension |
| 124934582 | 12493458 | 4 | Depression |
| 124934582 | 12493458 | 5 | Hyperlipidaemia |
| 124934582 | 12493458 | 6 | Depression |
| 124934582 | 12493458 | 7 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124934582 | 12493458 | HO |
| 124934582 | 12493458 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124934582 | 12493458 | C-reactive protein increased | |
| 124934582 | 12493458 | Colitis microscopic | |
| 124934582 | 12493458 | Enteritis | |
| 124934582 | 12493458 | Gastrointestinal disorder | |
| 124934582 | 12493458 | Hypokalaemia | |
| 124934582 | 12493458 | Hypoproteinaemia | |
| 124934582 | 12493458 | Malabsorption | |
| 124934582 | 12493458 | Renal failure | |
| 124934582 | 12493458 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124934582 | 12493458 | 1 | 201308 | 0 |